138 related articles for article (PubMed ID: 9593221)
1. Effects of rabeprazole, a gastric proton pump inhibitor, on biliary and hepatic lysosomal enzymes in rats.
Fujisaki H; Oketani K; Nagakawa J; Takenaka O; Yamanishi Y
Jpn J Pharmacol; 1998 Mar; 76(3):279-88. PubMed ID: 9593221
[TBL] [Abstract][Full Text] [Related]
2. Lack of effect of omeprazole, a potent inhibitor of gastric (H+ + K+) ATPase, on hepatic lysosomal integrity and enzyme activity.
Grinpukel S; Sewell R; Yeomans N; Mihaly G; Smallwood R
J Pharm Pharmacol; 1986 Feb; 38(2):158-60. PubMed ID: 2870166
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic perturbation of rat liver lysosomes: effects on release of lysosomal enzymes and of lipids into bile.
Sewell RB; Grinpukel SA; Zinsmeister AR; LaRusso NF
Gastroenterology; 1988 Oct; 95(4):1088-98. PubMed ID: 3137115
[TBL] [Abstract][Full Text] [Related]
4. Effect of chloroquine on the form and function of hepatocyte lysosomes. Morphologic modifications and physiologic alterations related to the biliary excretion of lipids and proteins.
Sewell RB; Barham SS; LaRusso NF
Gastroenterology; 1983 Nov; 85(5):1146-53. PubMed ID: 6413291
[TBL] [Abstract][Full Text] [Related]
5. Specific proton pump inhibitors E3810 and lansoprazole affect the recovery process of gastric secretion in rats differently.
Tomiyama Y; Morii M; Takeguchi N
Biochem Pharmacol; 1994 Nov; 48(11):2049-55. PubMed ID: 7802694
[TBL] [Abstract][Full Text] [Related]
6. Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.
Li XQ; Andersson TB; Ahlström M; Weidolf L
Drug Metab Dispos; 2004 Aug; 32(8):821-7. PubMed ID: 15258107
[TBL] [Abstract][Full Text] [Related]
7. Effects of proton pump inhibitors on thyroid hormone metabolism in rats: a comparison of UDP-glucuronyltransferase induction.
Masubuchi N; Hakusui H; Okazaki O
Biochem Pharmacol; 1997 Dec; 54(11):1225-31. PubMed ID: 9416973
[TBL] [Abstract][Full Text] [Related]
8. Ethanol impairs biliary lysosomal enzyme release in rats.
Sewell RB; Grinpukel SA; Yeomans ND
Clin Exp Pharmacol Physiol; 1986 Oct; 13(10):745-50. PubMed ID: 3802579
[TBL] [Abstract][Full Text] [Related]
9. Mobilization of gastric histamine during repeated administration of a proton potassium adenosine triphosphatase inhibitor in intact and antrectomized rats.
Miyazaki Y; Shinomura Y; Higashimoto Y; Imamura I; Fukui H; Aoki T; Okuda Y; Narita T; Miwa K; Miyazaki I
Regul Pept; 1995 Jul; 58(1-2):47-54. PubMed ID: 8570859
[TBL] [Abstract][Full Text] [Related]
10. Effect of rabeprazole (E3810), a novel proton pump inhibitor, on intragastric pH in healthy volunteers.
Hongo M; Kimpara T; Moriyama S; Ohara S; Sone S; Tamura T; Asaki S; Toyota T
Tohoku J Exp Med; 1998 Sep; 186(1):43-50. PubMed ID: 9915106
[TBL] [Abstract][Full Text] [Related]
11. Inhibitions of acid secretion by E3810 and omeprazole, and their reversal by glutathione.
Fujisaki H; Shibata H; Oketani K; Murakami M; Fujimoto M; Wakabayashi T; Yamatsu I; Yamaguchi M; Sakai H; Takeguchi N
Biochem Pharmacol; 1991 Jul; 42(2):321-8. PubMed ID: 1650210
[TBL] [Abstract][Full Text] [Related]
12. Effect of rabeprazole on histamine synthesis in enterochromaffin-like cells of mast cell-deficient (Ws/Ws) rats.
Nakamura S; Watanabe H; Yokota T; Matsui H; Onji M; Maeyama K
Eur J Pharmacol; 2000 Apr; 394(1):9-16. PubMed ID: 10771028
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the interaction potential of a new proton pump inhibitor, E3810, versus omeprazole with diazepam in extensive and poor metabolizers of S-mephenytoin 4'-hydroxylation.
Ishizaki T; Chiba K; Manabe K; Koyama E; Hayashi M; Yasuda S; Horai Y; Tomono Y; Yamato C; Toyoki T
Clin Pharmacol Ther; 1995 Aug; 58(2):155-64. PubMed ID: 7648765
[TBL] [Abstract][Full Text] [Related]
14. Quantitative importance of biliary excretion to the turnover of hepatic lysosomal enzymes.
Nakano A; Marks DL; Tietz PS; de Groen PC; LaRusso NF
Hepatology; 1995 Jul; 22(1):262-6. PubMed ID: 7601420
[TBL] [Abstract][Full Text] [Related]
15. Hepatic lysosomal enzymes activity and liver morphology after short-time omeprazole administration.
Burdan F; Siezieniewska Z; Maciejewski R; Madej B; Radzikowska E; Wojtowicz Z
Exp Toxicol Pathol; 2002 Feb; 53(6):453-9. PubMed ID: 11926287
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori urease inhibition by rabeprazole, a proton pump inhibitor.
Tsuchiya M; Imamura L; Park JB; Kobashi K
Biol Pharm Bull; 1995 Aug; 18(8):1053-6. PubMed ID: 8535394
[TBL] [Abstract][Full Text] [Related]
17. Triton WR-1339, a lysosomotropic compound, is excreted into bile and alters the biliary excretion of lysosomal enzymes and lipids.
LaRusso NF; Kost LJ; Carter JA; Barham SS
Hepatology; 1982; 2(2):209-15. PubMed ID: 6802741
[TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of the gastric H+,K(+)-ATPase by omeprazole and related compounds.
Lorentzon P; Bayati A; Lee H; Andersson K
Ann N Y Acad Sci; 1997 Nov; 834():592-9. PubMed ID: 9405870
[No Abstract] [Full Text] [Related]
19. Biliary excretion of iron from hepatocyte lysosomes in the rat. A major excretory pathway in experimental iron overload.
LeSage GD; Kost LJ; Barham SS; LaRusso NF
J Clin Invest; 1986 Jan; 77(1):90-7. PubMed ID: 3944262
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of inhibition of H+, K(+)-ATPase by sodium 2-[[4-(3- methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1H-benzimidazole (E3810).
Nochi S; Yokoyama Y; Narukawa M; Ebine K; Murahashi M; Kawakami Y; Asakawa N; Sato T
Chem Pharm Bull (Tokyo); 1996 Mar; 44(3):552-8. PubMed ID: 8882453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
